VetClick logo News
Friday, 25th May 2012 | 3517 veterinary jobs online | 269 people actively seeking work | 3432 practices registered
Veterinary News /

Snake Venom Level Findings To Be Presented At IVECCS

Author: BioVeteria Life Sciences, LLC
Posted: Wednesday 31st August, 2011. 20:04:15

BioVeteria Life Sciences, LLC (BioVeteria) will present their venom level findings at the 2011 International Veterinary Emergency and Critical Care Conference. The abstract, entitled “Neutralizing effects of F(ab’)2 antivenom on serum pit viper venom levels in dogs”, will be presented by Dr. Karen Seibold, a Diplomate of the American College of Veterinary Emergency and Critical Care.

The study evaluated the level of circulating venom in 55 dogs before and after treatment with a F(ab’)2 snake antivenom. Serum samples were collected at various clinics in Texas, Arizona, Florida and California. Serum venom levels were evaluated before antivenom administration and then at 3, 6, 12 and 24 hours after F(ab’)2 antivenom administration. The findings showed that administration of the F(ab’)2 pit viper antivenom resulted in an immediate and prolonged drop of venom levels. Results were highly significant and are being prepared for submission to a peer-reviewed publication.

About F(ab’)2 antivenoms

BioVeteria produces antivenoms using antibody fragments, called “Fragment antigen binding (Fab) dimers”, or “F(ab’)2”. BioVeteria’s F(ab’)2 antivenom has been previously shown to neutralize all common North American pit viper venoms, and consists of F(ab’)2 antibody fragments, which makes it properties different from whole IgG and Fab antivenoms. BioVeteria’s F(ab’)2 pit viper antivenom has broad neutralizing properties against all common North American pit vipers.

About BioVeteria Life Sciences, LLC

BioVeteria is a privately held bioscience company that is developing a range of new products for veterinary medicine, including F(ab’)2 antivenoms, optimized nutraceuticals, diagnostics and devices for veterinary applications. Located in historic Prescott, Arizona, BioVeteria is dedicated to advancing clinically meaningful technology for dogs, cats, and horses.

This article has been viewed 675 times.

 

Comments about this article

Most recent from this author

BioVeteria Launches LeukoSTAT®

BioVeteria Life Sciences, LLC BioVeteria Life Sciences, LLC (BioVeteria) announced they have partnered with IMULAN BioTherapeutics, LLC to distribute a new 60-count vers...
Posted: Friday 9th December, 2011. 12:14:47

BioVeteria Licenses Regenerative Technology For Cartilage And Bone

BioVeteria Life Sciences, LLC BioVeteria's exclusive license covers an orally active cartilage and bone regeneration technology licensed for the multi-billion dollar anim...
Posted: Wednesday 20th July, 2011. 09:53:33

New F(ab’)2 Rattlesnake Antivenom Efficacy Study Completed

BioVeteria Life Sciences, LLC BioVeteria Life Sciences, LLC (BioVeteria) announced the completion of a multi-center canine efficacy and safety study using a new F(ab’)2 a...
Posted: Thursday 5th May, 2011. 18:11:41

More BioVeteria Life Sciences, LLC news items...


Related



VetClick™ provides internet services for busy veterinary professionals. Jobs, staff, news, forum, referral practices, practice websites and veterinary consumables

All material on this website © Copyright VetClick (UK) Ltd 2000 - 2012 All rights reserved

Web design, web development and maintenance by Symbiotic

Monitored by Pingdom